What's New in Critical Illness and Injury Science? Alteplase for severe coronavirus disease 2019: Not quite ready to clot bust just hypoxemia.
作者信息
Areti Sathya, Maki Marwa K, Remy Kenneth E
机构信息
Department of Medicine, Case Western University School of Medicine, University Hospitals of Cleveland, Cleveland, OH, USA.
Department of Pediatrics, Case Western University School of Medicine, Rainbow Babies and Children's Hospital, Cleveland, OH, USA.
出版信息
Int J Crit Illn Inj Sci. 2022 Oct-Dec;12(4):181-183. doi: 10.4103/ijciis.ijciis_82_22. Epub 2022 Dec 26.
Abstract
摘要
相似文献
1
What's New in Critical Illness and Injury Science? Alteplase for severe coronavirus disease 2019: Not quite ready to clot bust just hypoxemia.
Int J Crit Illn Inj Sci. 2022 Oct-Dec;12(4):181-183. doi: 10.4103/ijciis.ijciis_82_22. Epub 2022 Dec 26.
2
What's new in critical illness and injury science? Convalescent plasma for coronavirus disease-2019 patients with severe or critical illness.
Int J Crit Illn Inj Sci. 2021 Jan-Mar;11(1):1-3. doi: 10.4103/ijciis.ijciis_26_21. Epub 2021 Mar 27.
3
What's new in critical illness and injury science? Intravenous immunoglobulin for COVID-19 with severe or critical illness.
Int J Crit Illn Inj Sci. 2020 Oct-Dec;10(4):159-162. doi: 10.4103/IJCIIS.IJCIIS_192_20. Epub 2020 Dec 29.
4
What's New in Critical Illness and Injury Science? Delirium, COVID-19, and critical illness.
Int J Crit Illn Inj Sci. 2022 Apr-Jun;12(2):59-60. doi: 10.4103/ijciis.ijciis_44_22. Epub 2022 Jun 24.
5
What's New in Critical Illness and Injury Science? Antibiotics in critical care: Therapeutic toolbox.
Int J Crit Illn Inj Sci. 2019 Jul-Sep;9(3):105-109. doi: 10.4103/IJCIIS.IJCIIS_81_19. Epub 2019 Sep 30.
6
What's new in critical illness and injury science? The costs of having a fall in Qatar!
Int J Crit Illn Inj Sci. 2013 Jan;3(1):1-2. doi: 10.4103/2229-5151.109405.
7
What's New in Critical Illness and Injury Science? We must lead by hope….
Int J Crit Illn Inj Sci. 2017 Apr-Jun;7(2):75-76. doi: 10.4103/IJCIIS.IJCIIS_37_17.
8
What's New in Critical Illness and Injury Science? Extubation Failure Predictors for 2016.
Int J Crit Illn Inj Sci. 2016 Oct-Dec;6(4):163-164. doi: 10.4103/2229-5151.195391.
9
What's new in critical illness and injury science? State of the art in management of ARDS.
Int J Crit Illn Inj Sci. 2014 Apr;4(2):95-7. doi: 10.4103/2229-5151.134140.
10
What's New in Critical Illness and Injury Science? A Look into Trauma Airway Management.
Int J Crit Illn Inj Sci. 2020 Jan-Mar;10(1):1-3. doi: 10.4103/IJCIIS.IJCIIS_14_20. Epub 2020 Mar 6.
本文引用的文献
1
Pulmonary embolism in patients with severe COVID-19 treated with systemic low-dose thrombolytic therapy: A case series.
Int J Crit Illn Inj Sci. 2022 Oct-Dec;12(4):235-238. doi: 10.4103/ijciis.ijciis_53_22. Epub 2022 Dec 26.
2
Systemic thrombolytics as rescue therapy for COVID-19 patients with acute respiratory distress syndrome: A retrospective observational study.
Int J Crit Illn Inj Sci. 2022 Oct-Dec;12(4):197-203. doi: 10.4103/ijciis.ijciis_45_22. Epub 2022 Dec 26.
3
Thromboelastography Parameters do not Discriminate for Thrombotic Events in Hospitalized Patients With COVID-19.
J Intensive Care Med. 2023 May;38(5):449-456. doi: 10.1177/08850666221142265. Epub 2022 Nov 29.
4
Hypercoagulability in critically ill patients with COVID 19, an observational prospective study.
PLoS One. 2022 Nov 23;17(11):e0277544. doi: 10.1371/journal.pone.0277544. eCollection 2022.
5
Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies.
Acta Pharmacol Sin. 2023 Apr;44(4):695-709. doi: 10.1038/s41401-022-00998-0. Epub 2022 Oct 17.
6
Anticoagulation in hospitalized patients with COVID-19.
Blood. 2022 Aug 25;140(8):809-814. doi: 10.1182/blood.2021014527.
7
MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID-19 severe respiratory failure (MUST COVID): A retrospective cohort study.
Res Pract Thromb Haemost. 2022 Mar 21;6(2):e12669. doi: 10.1002/rth2.12669. eCollection 2022 Feb.
8
Anticoagulation in COVID-19.
Lancet. 2022 Jan 1;399(10319):5-7. doi: 10.1016/S0140-6736(21)02503-4. Epub 2021 Dec 15.
9
Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19: A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized Controlled Trial.
Chest. 2022 Mar;161(3):710-727. doi: 10.1016/j.chest.2021.09.024. Epub 2021 Sep 27.
10
Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave.
Thromb Res. 2021 Mar;199:143-148. doi: 10.1016/j.thromres.2020.12.019. Epub 2020 Dec 30.
Zotero 插件